Denmark in a strong position regarding the location of the European Medicines Agency (EMA)

13-11-2017

Written byRandi Munch Krogsgaard, Cluster Manager

Compared to Stockholm and Helsinki Copenhagen gets full marks.

The voting on EMA future location is expected ultimo November 2017.

EMA has high demands to a new host country and capital and has ranked the capitals of the Nordic Countries. Read why Denmark has a high ranking at LIF's news page (Ext URL)

And read and download Denmark's proposal

Denmark's proposal to EMA

Latest news

News

Scouting for interesting projects at IP Fair

31-05-2018

On 29 May Biopeople participated in the IP Fair, along with companies, investors, entrepreneurial researchers and university business developers

News

Immunotherapy on the agenda – on Bioagora 2018 too

30-05-2018

Immunotherapy for the treatment of cancer is on the agenda of researchers as well as health care sector and politicians. The topic is also reflected...

People with diabetes would like to participate in public and commercial research.

News

Patients would like to contribute to research

03-05-2018

People with diabetes would like to participate in public and commercial research, contributing to the development of new insights into diabetes and...

Denmark in a strong position regarding the location of the European Medicines Agency (EMA)

Downloads

Related

Latest news